Navigation Links
Top Monash researchers recognised with NHMRC Excellence Awards
Date:6/18/2014

Four of the NHMRC's 20 top prizes for excellence in health and medical research have been awarded to Monash researchers.

The National Health and Medical Research Council's Research Excellence Awards are presented to the top-ranked applicants across NHMRC's funding schemes.

Professor Jamie Rossjohn, Associate Professor Allen Cheng, Associate Professor Terry Haines and Dr Michael Roche all from the Faculty of Medicine, Nursing and Health Sciences, will accept their awards at the NHMRC's 200th Council Dinner this evening.

Federal Minister for Health Peter Dutton will present the awards, which highlight innovative and potentially transformative research.

NHMRC Australia Fellow Professor Rossjohn, who is to receive the Highest Ranked Project Grant, is a leading international expert on processes central to infection and immunity.

The grant will allow him to further investigate a type of T-cell, termed MAIT cell, that is found in abundance in the gastrointestinal system. The research may pave the way for the development of drugs that could either stimulate or suppress activity of this type of T-cell, potentially improving treatments for conditions such as tuberculosis and inflammatory bowel disease.

"My colleagues and I were delighted to receive NHMRC project grant funding to continue our work on MAIT cells and by the subsequent recognition by the NHMRC," Professor Jamie Rossjohn said.

Associate Professor Allen Cheng from the Department of Epidemiology and Preventive Medicine receives the Highest Ranked Career Development Fellowship Clinical, Level 2.

Based in the Department of Epidemiology & Preventative Medicine, Associate Professor Cheng is also Deputy Head of the Infection Prevention and Healthcare Epidemiology Unit at Alfred Health in Melbourne.

The Fellowship will enable Associate Professor Cheng to research ways to prevent and treat significant infections.

"I'm grateful t
'/>"/>

Contact: Lucy Handford
lucy.handford@monash.edu
Monash University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. No link found between soy food and endometrial cancer risk, say researchers
2. Researchers use virus to reveal nanopore physics
3. Researchers identify regulation process of protein linked to bipolar disorder
4. Researchers develop free online database for soybean studies
5. NYU and UCSF researchers develop a framework for monitoring oral cancer
6. LSTM researchers identify the complex mechanisms controlling changes in snake venom
7. CU researchers explain mechanism that helps viruses spread
8. UNC researchers pinpoint new role for enzyme in DNA repair, kidney cancer
9. EcoHealth 2014 connects researchers addressing impacts of global change on health and ecosystems
10. Iowa State, Ames Lab researchers find the mechanism that forms cell-to-cell catch bonds
11. Race could be a factor in head and neck cancer survival rates, MU researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... 2013 BioNano Genomics , the developer of the Irys™ ... Fahim Amini , Ph.D. as vice president, Commercial Operations EMEA. ... System, making it possible for researchers and clinicians in ... Africa to access BioNano,s recently launched Irys platform. ...
... BioPharma, Inc. today announced that it has begun oral dosing ... ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside ... RSV infection. It is the only known nucleoside analog ... ALS-8176 demonstrates potent anti-viral activity across multiple strains of RSV ...
... uses pedometers to monitor how much people move throughout the ... a particular problem for office workers, and helping participants drop ... minutes a day, the fact that they,re sitting and not ... the day is in and of itself detrimental to their ...
Cached Biology News:BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA 2BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA 3Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection 2Study: Pedometer program helps motivate participants to sit less, move more 2
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Cytokinetics, Incorporated ... on February 28 with patients and health care advocates ... for Rare Disease Day®. Rare Disease Day is ... calling attention to the special challenges faced by patients ... , “Cytokinetics is proud to stand alongside patients and ...
(Date:2/26/2015)... S&P Capital IQ (MHFI) announced today that ... MabVax Therapeutics Holdings Inc . MabVax ... company focused on the development of vaccine and antibody-based ... of cancer. MabVax has discovered a pipeline of human ... generated by patients who have been immunized against targeted ...
(Date:2/26/2015)... TORONTO , Feb. 26, 2015 /PRNewswire/ - SQI ... SQIDF), a life sciences company that develops and commercializes ... reported its financial and operational results for the fiscal ... this press release are in Canadian dollars (CAD), unless ... Company continued to win new business from our existing ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Sept. 21 Nile Therapeutics Inc., (OTC,Bulletin Board: ... cardiovascular disease, is pleased to announce the,appointments of ... Jennifer,Hodge as the Vice President of Development. ... our Chief Operating Officer,and was appointed Chief Financial ...
... of Physics Dr. Satyendra Kumar recently was honored ... Directors Award for Excellence for recognition of exceptional ... matter physics proposals. In all, seven program directors ... Arlington, Va. , The NSF Directors Award ...
... China, Sept. 20 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC ... Chinese firm specializing in the manufacture,research, development, ... it has launched its newest product, Shining ... the Shanghai and Changchun markets. Shining ...
Cached Biology Technology:Nile Therapeutics, Inc. Adds to Executive Management Team 2Nile Therapeutics, Inc. Adds to Executive Management Team 3Nile Therapeutics, Inc. Adds to Executive Management Team 4China-Biotics, Inc. Launches Shining Probiotics Protein Powder 2
...
SpectroQuest single beam 4nm UV/Vis spectrophotometer; stand-alone unit; large angled LCD screen; large sample compartment...
Fluorescence Preserving Media, 100 mL...
... Blunt-Ended PCR Cloning Kit, 40 reactions. ... cloning of all PCR products with ... cloning approaches by offering consistently better ... 25-fold more positive clones.Amplicons generated by ...
Biology Products: